Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
View: Text | PDF
Research Article Gastroenterology Neuroscience

Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity

  • Text
  • PDF
Abstract

Itch induces scratching that removes irritants from the skin, whereas pain initiates withdrawal or avoidance of tissue damage. While pain arises from both the skin and viscera, we investigated whether pruritogenic irritant mechanisms also function within visceral pathways. We show that subsets of colon-innervating sensory neurons in mice express, either individually or in combination, the pruritogenic receptors Tgr5 and the Mas-gene–related GPCRs Mrgpra3 and Mrgprc11. Agonists of these receptors activated subsets of colonic sensory neurons and evoked colonic afferent mechanical hypersensitivity via a TRPA1-dependent mechanism. In vivo intracolonic administration of individual TGR5, MrgprA3, or MrgprC11 agonists induced pronounced visceral hypersensitivity to colorectal distension. Coadministration of these agonists as an “itch cocktail” augmented hypersensitivity to colorectal distension and changed mouse behavior. These irritant mechanisms were maintained and enhanced in a model of chronic visceral hypersensitivity relevant to irritable bowel syndrome. Neurons from human dorsal root ganglia also expressed TGR5, as well as the human ortholog MrgprX1, and showed increased responsiveness to pruritogenic agonists in pathological states. These data support the existence of an irritant-sensing system in the colon that is a visceral representation of the itch pathways found in skin, thereby contributing to sensory disturbances accompanying common intestinal disorders.

Authors

Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley

×

Figure 11

Human DRG neurons coexpress TRG5, MrgprX1, Trpv1, and Trpa1.

Options: View larger image (or click on image) Download as PowerPoint
Human DRG neurons coexpress TRG5, MrgprX1, Trpv1, and Trpa1.
(A) qPCR an...
(A) qPCR analysis from colonic biopsies from healthy human subjects show low levels of mRNA expression for Tgr5 and absent MrgprX1 (human ortholog of the mouse Mrgpra3 and Mrgprc11) compared with a known epithelial target gucy2c (GC-C, ****P < 0.0001, N = 15 subjects. Dots represent averaged values from each patient sample). (B) qPCR expression analysis of whole human thoracolumbar (TL; T9-L1) DRG from 4 human donors. Analysis reveals abundant expression of MrgprX1, Trpv1, and Trpa1, plus expression of the bile acid receptor Tgr5. Dots represent averaged values from each donor at each DRG level. (C) Single-cell RT-PCR analysis showing the percentage of individual human DRG neurons expressing the Tgr5, MrgprX1, Trpv1, and Trpa1. Data show that, of the 85 individual human thoracolumbar DRG neurons examined, 38% express Tgr5, 79% express MrgprX1, 92% expressed Trpv1, with 58% expressing Trpa1. (D) Donut plot analysis showing coexpression profiles of 85 individual human TL DRG neurons using single-cell RT-PCR for Tgr5, MrgprX1, Trpv1, and Trpa1. (E) Of the 38% of human TL DRG neurons expressing Tgr5, 78% coexpress MrgprX1, 97% coexpress Trpv1, with 56% coexpressing Trpa1. (F) Of the 79% of human DRG neurons expressing MrgprX1, 37% coexpress Tgr5, 99% coexpress Trpv1, with 60% coexpressing Trpa1. (G) Trpv1-expressing human DRG neurons also express Tgr5 (40%), MrgprX1 (85%), and Trpa1 (62%). (H) Trpa1-expressing human DRG neurons also express Tgr5 (31%), MrgprX1 (82%), and Trpv1 (98%). Data in A and B represent mean ± SEM. P values determined by 1-way ANOVA with Tukey’s multiple comparison tests (A).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts